Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12799615 | 0.81 | HSD17B10 (0.39) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL4421747 | 0.79 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL28889640 | 0.73 | HSD17B10 (0.39) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL9707362 | 0.71 | HPRT1 (0.54) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL1287806 | 0.71 | CA12 (0.47) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL1159909 | 0.69 | HSD17B10 (0.44) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL634543 | 0.68 | HSD17B10 (0.42) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL31668742 | 0.68 | HSD17B10 (0.42) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL4298702 | 0.67 | HSD17B10 (0.46) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL31301198 | 0.67 | ALDH1A1 (0.41) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137819-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4598928-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | claimed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | claimed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | claimed |
| WO-2024077006-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-04-11 | — | — | WO | claimed |
| CN-109503487-B | Dihydrobenzandazole compound, organic electroluminescent device and display device | 阜阳欣奕华材料科技有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-109678799-B | Dihydrobenzandazole compound, organic electroluminescent device and display device | 阜阳欣奕华材料科技有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-109535130-B | Dihydrobenzandazole compound, organic electroluminescent device and display device | 阜阳欣奕华材料科技有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-109721540-A | Dihydrobenzo indazole compounds, organic electroluminescence device and display device | 阜阳欣奕华材料科技有限公司 | 2019-05-07 | — | — | CN | claimed |
| CN-109207145-A | A kind of organic electroluminescence device and display | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| CN-109206414-A | Dihydrobenzo indazole class electroluminescent organic material | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| CN-109206369-A | A kind of dihydrobenzo indazole class electroluminescent organic material | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| CN-109206368-A | A kind of dihydrobenzo indazole class electroluminescent organic material | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| CN-109206412-A | A kind of organic electroluminescence device and display | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| CN-109206404-A | A kind of dihydrobenzo indazole class electroluminescent organic material | 李现伟 | 2019-01-15 | — | — | CN | claimed |
| EP-2459551-B1 | DIHYDROBENZOINDAZOLES | MERCK SHARP & DOHME (NL) | 2014-07-02 | — | — | EP | claimed |
| EP-2459551-A1 | DIHYDROBENZOINDAZOLES | MSD Oss B.V. (NL) | 2012-06-06 | — | — | EP | claimed |
| WO-2011012674-A1 | DIHYDROBENZOINDAZOLES | N.V. ORGANON (NL) | 2011-02-03 | — | — | WO | claimed |
| US-20110028451-A1 | Dihydrobenzoindazoles | N.V. ORGANON (NL) | 2011-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | AMD1, HNMT, MAT1A | ALDH1A1 317/4885HSD17B10 2763/4885CYP2A6 4391/4885 |
| US-20110028451-A1 | Dihydrobenzoindazoles | DHODH, BRDT, HSD17B11 | ALDH1A1 54/4885HSD17B10 139/4885CYP2A6 786/4885 |
| US-20260137819-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | FSHR, GNRHR, LHCGR | ALDH1A1 3439/4885HSD17B10 568/4885CYP2A6 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.